ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

196 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 71.3M shares of 98.6M outstanding shares and own 72.33% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.9M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (10.5M shares), ORBIMED ADVISORS LLC (8.29M shares), BlackRock, Inc. (4.57M shares), SR One Capital Management, LP (4.01M shares), ALLIANCEBERNSTEIN L.P. (3.88M shares), VANGUARD GROUP INC (3.46M shares), STATE STREET CORP (2.75M shares), FRANKLIN RESOURCES INC (1.98M shares), and Alyeska Investment Group, L.P. (1.25M shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.